<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:format>application/pdf</dc:format>
  <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
  <dc:subject xml:lang="eng">BIMU-8</dc:subject>
  <dc:subject xml:lang="eng">Etorphine</dc:subject>
  <dc:subject xml:lang="eng">Opioid</dc:subject>
  <dc:subject xml:lang="eng">Vatinoxan</dc:subject>
  <dc:subject xml:lang="eng">Pulmonary Hypertension</dc:subject>
  <dc:subject xml:lang="eng">Cardiovascular</dc:subject>
  <dc:description xml:lang="eng">Background

Etorphine, a highly potent opioid widely used in wildlife immobilisation, is known to cause cardiorespiratory compromise. This study aimed to investigate the effects of a serotonergic agonist, BIMU-8 and an alpha-2 adrenoreceptor antagonist, vatinoxan on pulmonary hypertension and cardiovascular function in etorphine-immobilised sheep, as a model for wild ungulates. Six sheep were immobilised three times in a randomised, prospective, controlled crossover design using intramuscular etorphine (0.05 mg·kg−1). Seven minutes later, sheep received intravenous BIMU-8 (1.5 mg·kg−1), vatinoxan (0.15 mg·kg−1), or sterile water (control). Respiratory rate, pulmonary arterial, systemic arterial and central venous pressures, electrocardiography, heart rate, and cardiac output were recorded. Data were collected at resting state, six minutes post-etorphine, and at six-minute intervals post-treatment. Naltrexone was administered 19 minutes post-treatment to reverse immobilisation. Linear mixed-effects models were used for statistical analysis.

Results

Etorphine induced bradypnea, pulmonary hypertension, dysrhythmias, and tachycardia in sheep. BIMU-8 significantly reduced mean pulmonary arterial pressure (F2,91 = 4.17, p = 0.02) and mean arterial pressure (F2,89 = 6.01, p &lt; 0.01) but was associated with severe tachydysrhythmia. Vatinoxan decreased respiratory rate (F2,91 = 4.13, p &lt; 0.01), increased cardiac output (F2,91 = 10.88, p &lt; 0.01), and reduced body temperature (F6,85 = 2.2, p = 0.05), while having no effect on pulmonary or systemic arterial pressures.

Conclusion

BIMU-8 reduces etorphine-induced pulmonary and systemic hypertension, but causes tachydysrhythmias, requiring further evaluation. Vatinoxan improves cardiac output, without alleviating pulmonary hypertension in etorphine-immobilised sheep.</dc:description>
  <dc:title xml:lang="eng">Cardiovascular effects of a selective 5-HT4 agonist and an alpha-2 adrenoceptor antagonist in etorphine immobilised sheep (Ovis aries) - a randomised, prospective, and controlled trial</dc:title>
  <dc:language>eng</dc:language>
  <dc:rights xml:lang="ita">Open Access</dc:rights>
  <dc:type xml:lang="deu">Text</dc:type>
  <dc:type xml:lang="deu">Wissenschaftlicher Artikel</dc:type>
  <dc:type xml:lang="eng">Text</dc:type>
  <dc:type xml:lang="eng">journal article</dc:type>
  <dc:source xml:lang="eng">BMC Veterinary Research</dc:source>
  <dc:identifier>doi:10.1186/s12917-026-05379-x</dc:identifier>
  <dc:date>2026</dc:date>
  <dc:rights xml:lang="eng">© The Author(s) 2026</dc:rights>
  <dc:rights xml:lang="eng">open access</dc:rights>
  <dc:publisher>Springer</dc:publisher>
  <dc:creator>Hathaipat Rattanathanya (Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Anna Binetti (Clinical Centre for Small Animal Health and Research, Clinical Department for Small Animals and Horses, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Friederike Pohlin (Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Susana C.M. Ferreira (Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Christina Braun (Clinical Centre for Small Animal Health and Research, Clinical Department for Small Animals and Horses, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Johannes Schramel (Clinical Centre for Small Animal Health and Research, Clinical Department for Small Animals and Horses, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Leith C.R. Meyer</dc:creator>
  <dc:creator>Anna Haw (Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Marja Raekallio</dc:creator>
  <dc:creator>Stefan Böhmdorfer</dc:creator>
  <dc:creator>Szilvia Kalogeropoulu (Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Martina Mosing (Clinical Centre for Small Animal Health and Research, Clinical Department for Small Animals and Horses, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Gabrielle Stalder (Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, Departments, University of Veterinary Medicine Vienna)</dc:creator>
  <dc:type xml:lang="ita">Documento PDF</dc:type>
  <dc:type xml:lang="ita">Articolo scientifico</dc:type>
  <dc:identifier>https://phaidra.vetmeduni.ac.at/o:5440</dc:identifier>
</oai_dc:dc>